title: Anesthetic drugs in congenital heart disease.
abstract: The structural defects associated with the various forms of congenital heart disease lead to pathological and functional changes that place patients at risk for adverse events, and in fact the perioperative incidence of morbidity and mortality has been documented to be increased in children with congenital heart disease. Patients with congenital heart disease can present to the anesthesiologist in a relatively precarious state of balance of several hemodynamic factors, including preload, ventricular contractility, systemic vascular resistance, pulmonary vascular resistance, heart rate, and cardiac rhythm. Anesthetic drugs can affect each of these, and an ideal anesthetic drug for such patients does not exist. The purpose of this article is to review the hemodynamic effects of anesthetic drugs and how they may contribute to the occurrence of adverse events in children with congenital heart disease.
authors: Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA Robert.Friesen@childrenscolorado.org.
authors: Robert H
authors: RH
authors: Friesen
mesh_terms: D000776:Anesthesiology / Q000379:methods; D000777:Anesthetics / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D006330:Heart Defects, Congenital / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control
chemical_list: D000777:Anesthetics
keywords: cardiac anesthesia; cardiovascular risk; children; congenital heart disease; perioperative mortality